Release Date: 23/04/19 08:22 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 1.24MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%